Carmichael Hill & Associates’s Mandiant, Inc. Common Stock MNDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-90
Closed -$2K 883
2022
Q2
$2K Hold
90
﹤0.01% 739
2022
Q1
$2K Hold
90
﹤0.01% 759
2021
Q4
$2K Hold
90
﹤0.01% 769
2021
Q3
$2K Hold
90
﹤0.01% 760
2021
Q2
$2K Hold
90
﹤0.01% 746
2021
Q1
$2K Hold
90
﹤0.01% 726
2020
Q4
$2K Hold
90
﹤0.01% 697
2020
Q3
$1K Hold
90
﹤0.01% 704
2020
Q2
$1K Hold
90
﹤0.01% 683
2020
Q1
$1K Hold
90
﹤0.01% 675
2019
Q4
$1K Buy
+90
New +$1.44K ﹤0.01% 682

Other funds holding MNDT

Carmichael Hill & Associates's MNDT Position: Q3 2022 in Review

Carmichael Hill & Associates sold out of Mandiant, Inc. Common Stock (MNDT) in Q3 2022, closing a stake of 90 shares — an estimated $2K sold.

Carmichael Hill & Associates first reported a position in MNDT in Q4 2019 and held it in 11 quarters. The position peaked at $2K in Q2 2022. 3 funds tracked by Wall St. Rank hold MNDT as of Q3 2022.

  • Carmichael Hill & Associates reported no remaining Mandiant, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Carmichael Hill & Associates sold 90 Mandiant, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • Carmichael Hill & Associates first reported a position in Mandiant, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
  • Carmichael Hill & Associates's Mandiant, Inc. Common Stock position peaked at $2K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Mandiant, Inc. Common Stock as of Q3 2022.

Based on Carmichael Hill & Associates's 13F filing for Q3 2022, filed 10 Nov 2022.